Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Frontiers in Medicine|November 10, 2022
Difficult-to-treat rheumatoid arthritis: Current concept and unsolved problemsRyu Watanabe, Tadashi Okano, Takaho Gon, et al.Biomolecules|November 27, 2025
The Type I Interferon Axis in Systemic Autoimmune Diseases: From Molecular Pathways to Targeted TherapyRyuhei Ishihara, Ryu Watanabe, Mayu Shiomi, et al.Biomolecules|July 27, 2024
Exploring the Link between Varicella-Zoster Virus, Autoimmune Diseases, and the Role of Recombinant Zoster VaccineRyuhei Ishihara, Ryu Watanabe, Mayu Shiomi, et al.Atherosclerosis|August 30, 2020
Predictors of endothelial function improvement in patients with mild hypertriglyceridemia without evidence of coronary artery disease treated with purified eicosapentaenoic acidKazuo Fukumoto, Yasuhiko Takemoto, Junichi Yoshikawa, et al.Cardiovascular Diabetology|May 20, 2023
Lack of impact of ipragliflozin on endothelial function in patients with type 2 diabetes: sub-analysis of the PROTECT studyShinji Kishimoto, Yukihito Higashi, Takumi Imai, et al.Hypertension Research : Official Journal of the Japanese Society of Hypertension|July 23, 2020
Predictors of the effects of smoking cessation on the endothelial function of conduit and digital vesselsKazuo Fukumoto, Yasuhiko Takemoto, Naoki Norioka, et al.International Journal of Molecular Sciences|March 29, 2023
Rheumatic Immune-Related Adverse Events due to Immune Checkpoint Inhibitors-A 2023 UpdateQuang Minh Dang, Ryu Watanabe, Mayu Shiomi, et al.Journal of Clinical Medicine|March 17, 2025
Rheumatoid Factor: Diagnostic and Prognostic Performance and Therapeutic Implications in Rheumatoid ArthritisTasuku Togashi, Ryuhei Ishihara, Ryu Watanabe, et al.Modern Rheumatology Case Reports|February 12, 2024
Lymphoproliferative disorder progressing after partial remission following immunosuppressive drugs withdrawal in a patient with rheumatoid arthritisKazuo Fukumoto, Ryu Watanabe, Minako Tsutsumi, et al.Journal of Clinical Medicine|May 13, 2026
Preclinical Rheumatoid Arthritis: Pathogenesis, Risk Stratification, and Therapeutic InterceptionYukina Mizuno Yokoyama, Ryu Watanabe, Mayu Shiomi, et al.Pageof 3